Phibro Animal Health | PAHC - Spese Operative





Spese Operative Cambiamento Data
Align Technology USD 864.87M 2.84M 2026-06
ANI Pharmaceuticals USD 597.21M 34.91M 2026-06
Aurora Cannabis CAD 48.04M 81.94M 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Canopy Growth CAD 98.72M 11.51M 2026-03
Corcept Therapeutics USD 214.85M 343K 2026-06
Eli Lilly USD 10.52B 496M 2026-06
Henry Schein USD 3.26B 84M 2026-06
Idexx Laboratories USD 791.02M 12.78M 2026-06
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Merck USD 15.77B 2.4B 2026-06
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Pacira USD 180.54M 7.79M 2026-06
Phibro Animal Health USD 361.83M 29.47M 2026-03
Prestige Brands USD 213.19M 7.06M 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
Zoetis USD 3.15B 85M 2026-06